Back
Regeneron Pharmaceuticals Vs. Tandem Diabetes Care Industry Stock Comparison
Buy
68
REGN
Regeneron Pharmaceuticals
Last Price:
1,037.33
Seasonality Move:
9.39%
Sell
46
TNDM
Tandem Diabetes Care
Last Price:
45.38
Seasonality Move:
20.45%
Buy
68
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $1,036.52. The Score for REGN is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Tandem Diabetes Care (TNDM)
is a Sell
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $45.33. The Score for TNDM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- TNDM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $1,036.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $45.33
The current trend is moderately bearish and TNDM is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 18.39 | Buy |
| Relative Strength Index (14 RSI): | 73.81 | Buy |
| Chaikin Money Flow: | 177271 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (972.61 - 1009.89) | Buy |
| Bollinger Bands (100): | (925.66 - 989.42) | Buy |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 44.36 | Sell |
| Chaikin Money Flow: | 864407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.03 - 51.67) | Sell |
| Bollinger Bands (100): | (25.46 - 44.48) | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1014.24 | Buy |
| 20-day SMA: | 994.99 | Buy |
| 50-day SMA: | 955.42 | Buy |
| 200-day SMA: | 898.52 | Buy |
| 8-day EMA: | 1015.86 | Buy |
| 20-day EMA: | 996.9 | Buy |
| 50-day EMA: | 972.53 | Buy |
| 200-day EMA: | 905.83 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.18 | Sell |
| 20-day SMA: | 49.73 | Sell |
| 50-day SMA: | 42.42 | Buy |
| 200-day SMA: | 28.56 | Buy |
| 8-day EMA: | 47.67 | Sell |
| 20-day EMA: | 47.9 | Sell |
| 50-day EMA: | 43.47 | Buy |
| 200-day EMA: | 34.22 | Buy |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.57 per share, and an increase next year of $3.32 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
Regeneron Pharmaceuticals Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||